Jinhe Biotechnology CO., LTD. (SHE:002688)
China flag China · Delayed Price · Currency is CNY
5.39
-0.10 (-1.82%)
Sep 10, 2026, 2:40 PM CST

SHE:002688 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
700.09618.35635.89608.13491.37517.66
Trading Asset Securities
0.981.380.550.51--
Cash & Short-Term Investments
701.07619.74636.45608.64491.37517.66
Cash Growth
11.92%-2.63%4.57%23.87%-5.08%64.44%
Accounts Receivable
613.76656.18659.9633.13504.86493.6
Other Receivables
58.8946.1616.5364.7912.1211.22
Receivables
672.64702.34676.43697.92516.98504.82
Inventory
774.9668.1635.28670.55675.91577.2
Prepaid Expenses
-1.850.230.20.250.31
Other Current Assets
80.7765.8172.3262.2762.0149.97
Total Current Assets
2,2292,0582,0212,0401,7471,650
Property, Plant & Equipment
2,3652,3702,3222,0521,6231,209
Long-Term Investments
12.1517.1617.1612.163.150.53
Goodwill
277.75282.11460.3497.95298.91295.97
Other Intangible Assets
619.42631.15639.94656.4629.72645.33
Long-Term Deferred Tax Assets
51.8950.7771.2150.0516.549.99
Long-Term Deferred Charges
62.6475.4392.12102.4388.3275.35
Other Long-Term Assets
46.5734.927.0342.98102.16178.59
Total Assets
5,6655,5195,6515,4544,5094,065

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
267.58298.57313.71254.91263.11122.04
Accrued Expenses
39.5752.0672.8499.6247.436.65
Short-Term Debt
577.16730.351,0321,6871,246833.9
Current Portion of Long-Term Debt
804.91465.81225.3782.3144.7985.24
Current Portion of Leases
-116.9575.827.136.561.95
Current Income Taxes Payable
27.943.2321.971.11.235.21
Current Unearned Revenue
17.5424.7417.9617.7725.6630.61
Other Current Liabilities
158.85110.46101.16107.7829.4248.08
Total Current Liabilities
1,8941,8021,8612,2571,6651,164
Long-Term Debt
967.31992.34965.79497.49296.2287
Long-Term Leases
14.27113.01154.6426.197.67-
Long-Term Unearned Revenue
63.2659.0956.1239.2438.0938.33
Long-Term Deferred Tax Liabilities
106.03108.99112.97116.8876.667.38
Other Long-Term Liabilities
133.45----11.64
Total Liabilities
3,1783,0763,1512,9372,0831,368

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
769.5769.53771.69780.42780.42780.42
Additional Paid-In Capital
879.78875.99879.51896.48888.961,079
Retained Earnings
723.61668.29715.52690.64679.56603.94
Treasury Stock
-94.16-94.28-138.86-131.89-131.89-
Comprehensive Income & Other
-7.698.8718.7511.144.61-25.2
Total Common Equity
2,2712,2282,2472,2472,2222,438
Minority Interest
215.77214.94253.25269.89203.63258.28
Shareholders' Equity
2,4872,4432,5002,5172,4252,696
Total Liabilities & Equity
5,6655,5195,6515,4544,5094,065

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2,3642,4182,4542,3001,6021,008
Net Cash (Debt)
-1,663-1,799-1,818-1,691-1,110-490.44
Net Cash Growth
------
Net Cash Per Share
-2.13-2.30-2.35-2.17-1.42-0.70
Filing Date Shares Outstanding
769.93755.68752.17753.75753.75780.42
Total Common Shares Outstanding
769.93755.71752.17753.75753.75780.42
Working Capital
335.84255.66159.49-217.7481.88486.27
Book Value Per Share
2.952.952.992.982.953.12
Tangible Book Value
1,3741,3151,1461,0921,2931,497
Tangible Book Value Per Share
1.781.741.521.451.721.92
Buildings
-1,2621,204918.97806.47671.81
Machinery
-2,2492,0321,5861,5151,145
Construction In Progress
-195.5246.27645.56300.79289.91